This article is part of the supplement: Specific conditions in UK critical care units: analyses from the Intensive Care National Audit & Research Centre Case Mix Programme Database,2008 .

Research article

Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit & Research Centre (ICNARC) Case Mix Programme Database

Susannah MC George¹ , David A Harrison², Catherine A Welch², Kathleen M Nolan³ and Peter S Friedmann⁴

¹Clinical Teaching Fellow in Specialties (Dermatology), St Helier Hospital, Wrythe Lane, Carshalton, Surrey SM5 1AA, UK

²Intensive Care National Audit & Research Centre, Tavistock House, Tavistock Square, London WC1H 9HR, UK

³Critical Care Directorate, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK

⁴University of Southampton, Dermatopharmacology Unit, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK

author email corresponding author email

Critical Care 2008, 12(Suppl 1):S1doi:10.1186/cc6141

Published:	18 January 2008

Abstract

Introduction

Dermatology is usually thought of as an outpatient specialty with low mortality, however some skin conditions require intensive care. These conditions are relatively rare and hence are best studied using clinical databases or disease registries. We interrogated a large, high-quality clinical database from a national audit of adult intensive care units (ICUs), with the aim of identifying and characterising patients with dermatological conditions requiring admission to ICU.

Methods

Data were extracted for 476,224 admissions to 178 ICUs in England, Wales and Northern Ireland participating in the Case Mix Programme over the time period December 1995 to September 2006. We identified admissions with dermatological conditions from the primary and secondary reasons for admission to ICU.

Results

A total of 2,245 dermatological admissions were identified. Conditions included infectious conditions (e.g. cutaneous cellulitis, necrotising fasciitis), dermatological malignancies, and acute skin failure (e.g. toxic epidermal necrolysis, Stevens–Johnson syndrome and autoimmune blistering diseases). These represent 0.47% of all ICU admissions, or approximately 2.1 dermatological admissions per ICU per year. Overall mortality was 28.1% in the ICU and 40.0% in hospital. Length of stay in intensive care was longest for those with acute skin failure (median 4.7 days for ICU survivors and 5.1 days for ICU non-survivors).

Conclusion

We have identified patients who not only require intensive care, but also dermatological care. Such patients have high mortality rates and long ICU stays within the spectrum of the UK ICU population, similar to other acute medical conditions. This highlights the importance of skin failure as a distinct entity comparable to other organ system failures.